Skip to content
August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Moving Through the Storm: The Vital Role of Physical Activity During Chemotherapy moving-through-the-storm-the-vital-role-of-physical-activity-during-chemotherapy
  • Survivorship and Post-Treatment

Moving Through the Storm: The Vital Role of Physical Activity During Chemotherapy

Siti Muinah July 30, 2026
By [Your Name/Journalistic Staff] For many patients, a cancer diagnosis and the subsequent prescription of chemotherapy trigger...
Read More Read more about Moving Through the Storm: The Vital Role of Physical Activity During Chemotherapy
WTWH Media Rebrands as Arrowfly: A New Chapter for the B2B Media Powerhouse wtwh-media-rebrands-as-arrowfly-a-new-chapter-for-the-b2b-media-powerhouse
  • Chemotherapy and Targeted Therapy

WTWH Media Rebrands as Arrowfly: A New Chapter for the B2B Media Powerhouse

Nana July 30, 2026
By Editorial Staff In a major strategic evolution within the B2B media landscape, the Cleveland-based media and...
Read More Read more about WTWH Media Rebrands as Arrowfly: A New Chapter for the B2B Media Powerhouse
The Silent Burden: Addressing the Unique Mental Health Challenges of Previvors the-silent-burden-addressing-the-unique-mental-health-challenges-of-previvors
  • Survivorship and Post-Treatment

The Silent Burden: Addressing the Unique Mental Health Challenges of Previvors

Siti Muinah July 30, 2026
By Editorial Staff June 30, 2026 In the landscape of modern oncology, a new demographic has emerged...
Read More Read more about The Silent Burden: Addressing the Unique Mental Health Challenges of Previvors
The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment the-panss-paradox-inside-maplights-volatile-market-reckoning-and-the-future-of-schizophrenia-treatment
  • Chemotherapy and Targeted Therapy

The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment

Reynand Wu July 30, 2026
In the high-stakes world of psychiatric drug development, success is rarely a straight line, and even more...
Read More Read more about The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment
Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries closing-the-data-gap-metavivor-spearheads-push-for-modernized-cancer-registries
  • Metastatic Breast Cancer Research

Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

Asro July 30, 2026
In the fight against cancer, data is often described as the compass that guides clinical research, drug...
Read More Read more about Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries
Unlocking the Enigma of Metastasis: How a Cellular "Identity Keeper" May Drive Colorectal Cancer Spread to the Liver unlocking-the-enigma-of-metastasis-how-a-cellular-identity-keeper-may-drive-colorectal-cancer-spread-to-the-liver
  • Medical Research and Clinical Trials

Unlocking the Enigma of Metastasis: How a Cellular "Identity Keeper" May Drive Colorectal Cancer Spread to the Liver

Azzam Bilal Chamdy July 30, 2026
New research from Weill Cornell Medicine and MIT sheds light on a critical epigenetic mechanism behind one...
Read More Read more about Unlocking the Enigma of Metastasis: How a Cellular "Identity Keeper" May Drive Colorectal Cancer Spread to the Liver
From Diagnosis to Determination: How One Man Redefined His "Second Life" After Cancer from-diagnosis-to-determination-how-one-man-redefined-his-second-life-after-cancer
  • Psychosocial Support and Mental Health

From Diagnosis to Determination: How One Man Redefined His "Second Life" After Cancer

Nana Muazin July 30, 2026
At the tender age of 18, when most young adults are preoccupied with the transition from high...
Read More Read more about From Diagnosis to Determination: How One Man Redefined His "Second Life" After Cancer
The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research the-arms-race-in-silicon-how-bristol-myers-squibbs-new-ai-supercomputer-redefines-pharma-research
  • Treatment Innovations

The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

Neng Nana July 30, 2026
In the high-stakes world of pharmaceutical R&D, the battle for drug discovery supremacy has shifted from the...
Read More Read more about The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research
Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation beyond-the-facelift-how-regenerative-medicine-and-plasma-resurfacing-are-redefining-facial-rejuvenation
  • Breast Cancer Surgery and Reconstruction

Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation

Pevita Pearce July 30, 2026
For decades, the surgical facelift has been the gold standard for addressing the physiological hallmarks of aging:...
Read More Read more about Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation
Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology elevation-spine-secures-fda-clearance-for-saber-c-avia-advancing-cervical-fusion-technology
  • Treatment Innovations

Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology

Laily UPN July 30, 2026
In a significant milestone for spinal orthopedics, Elevation Spine, a company renowned for its commitment to integrated-fixation...
Read More Read more about Elevation Spine Secures FDA Clearance for Saber-C AVIA: Advancing Cervical Fusion Technology

Posts pagination

Previous 1 … 45 46 47 48 49 50 51 … 418 Next

Recent Posts

  • The Transformation of U.S. Global Health: Assessing the Impact of Executive Restructuring
  • Bridging the Gap in Cancer Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act
  • Groundbreaking UMass Chan Research Redefines How Cancer Drugs Kill BRCA Mutant Cells, Offering New Hope Against Drug Resistance
  • Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial
  • The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-transformation-of-u-s-global-health-assessing-the-impact-of-executive-restructuring
  • Breast Cancer Legislation and Policy

The Transformation of U.S. Global Health: Assessing the Impact of Executive Restructuring

Nana Wu August 8, 2026
bridging-the-gap-in-cancer-research-metavivor-joins-coalition-to-champion-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Cancer Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Muslim August 8, 2026
groundbreaking-umass-chan-research-redefines-how-cancer-drugs-kill-brca-mutant-cells-offering-new-hope-against-drug-resistance
  • Medical Research and Clinical Trials

Groundbreaking UMass Chan Research Redefines How Cancer Drugs Kill BRCA Mutant Cells, Offering New Hope Against Drug Resistance

Lina Hope August 8, 2026
dispatch-bio-advances-promising-immunotherapy-for-advanced-gi-cancers-with-first-patient-dosed-in-phase-i-trial
  • Medical Research and Clinical Trials

Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial

Suro Senen August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.